Fscn1 inhibitors developed for tumor therapy attenuate the T cell stimulatory activity of dendritic cells
EUROPEAN JOURNAL OF IMMUNOLOGY(2022)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined